Chronic stable angina enhanced external counter pulsation: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
| Line 7: | Line 7: | ||
Enhanced external counter pulsation (EECP) is another alternative therapy in the management of refractory angina. Most data from observational studies have demonstrated significant improvement in the exercise tolerance and reduction in the frequency of [[Chronic stable angina symptoms|anginal symptoms]] as well as the use of [[Chronic stable angina treatment nitrates|nitroglycerin]] among patients treated with EECP.<ref name="pmid11153780">Urano H, Ikeda H, Ueno T, Matsumoto T, Murohara T, Imaizumi T (2001) [http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&retmode=ref&cmd=prlinks&id=11153780 Enhanced external counterpulsation improves exercise tolerance, reduces exercise-induced myocardial ischemia and improves left ventricular diastolic filling in patients with coronary artery disease.] ''J Am Coll Cardiol'' 37 (1):93-9. PMID: [http://pubmed.gov/11153780 11153780]</ref> | Enhanced external counter pulsation (EECP) is another alternative therapy in the management of refractory angina. Most data from observational studies have demonstrated significant improvement in the exercise tolerance and reduction in the frequency of [[Chronic stable angina symptoms|anginal symptoms]] as well as the use of [[Chronic stable angina treatment nitrates|nitroglycerin]] among patients treated with EECP.<ref name="pmid11153780">Urano H, Ikeda H, Ueno T, Matsumoto T, Murohara T, Imaizumi T (2001) [http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&retmode=ref&cmd=prlinks&id=11153780 Enhanced external counterpulsation improves exercise tolerance, reduces exercise-induced myocardial ischemia and improves left ventricular diastolic filling in patients with coronary artery disease.] ''J Am Coll Cardiol'' 37 (1):93-9. PMID: [http://pubmed.gov/11153780 11153780]</ref> | ||
==Mechanisms of Benefit== | ==Enhanced External Counter Pulsation== | ||
===Mechanisms of Benefit=== | |||
*EECP has been postulated to decrease myocardial oxygen demand, enhance myocardial collateral flow via increased transmyocardial pressure, and improve endothelial function. | *EECP has been postulated to decrease myocardial oxygen demand, enhance myocardial collateral flow via increased transmyocardial pressure, and improve endothelial function. | ||
| Line 16: | Line 17: | ||
*Possible placebo effect associated with EECP has not been addressed in many studies, which have not included sham controls. | *Possible placebo effect associated with EECP has not been addressed in many studies, which have not included sham controls. | ||
==Approach== | ===Approach=== | ||
EECP uses three paired pneumatic cuffs that are applied to the lower extremities. The cuffs are sequentially inflated then deflated. | EECP uses three paired pneumatic cuffs that are applied to the lower extremities. The cuffs are sequentially inflated then deflated. | ||
The therapy is usually administered over 7 weeks consisting of 35-one hour treatments. | The therapy is usually administered over 7 weeks consisting of 35-one hour treatments. | ||
==Supportive Trial Data== | ===Supportive Trial Data=== | ||
====Randomized-Controlled Study==== | ====Randomized-Controlled Study==== | ||
*A multicenter, prospective, randomized, blinded, controlled trial involving 139 patients with [[chronic stable angina definition|angina]], [[Chronic stable angina assessing the pretest probability of coronary artery disease|documented coronary artery disease]] and [[Chronic stable angina risk assessment in patients with an intermediate or high probability of coronary artery disease|positive exercise treadmill test]] randomly assigned to receive either EECP (35 hours of active counterpulsation) or inactive EECP (over a 4- to 7-week period) to determine the safety and efficacy of EECP. The study demonstrated a significant improvement in the time to [[ST segment depression]] from baseline in the active EECP group (P=0.01). More active-EECP patients experienced a significant reduction in the frequency of anginal episodes (P=less than 0.05); however, the usage of [[Chronic stable angina treatment nitrates|nitroglycerin]] did not significantly change in both the groups. Thus, the study concluded that enhanced external counterpulsation significantly reduced [[chronic stable angina definition|angina]] and extended the time to exercise-induced ischemia in patients with [[Chronic stable angina symptoms|symptomatic CAD]].<ref name="pmid10362181">Arora RR, Chou TM, Jain D, Fleishman B, Crawford L, McKiernan T et al. (1999) [http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&retmode=ref&cmd=prlinks&id=10362181 The multicenter study of enhanced external counterpulsation (MUST-EECP): effect of EECP on exercise-induced myocardial ischemia and anginal episodes.] ''J Am Coll Cardiol'' 33 (7):1833-40. PMID: [http://pubmed.gov/10362181 10362181]</ref> | *A multicenter, prospective, randomized, blinded, controlled trial involving 139 patients with [[chronic stable angina definition|angina]], [[Chronic stable angina assessing the pretest probability of coronary artery disease|documented coronary artery disease]] and [[Chronic stable angina risk assessment in patients with an intermediate or high probability of coronary artery disease|positive exercise treadmill test]] randomly assigned to receive either EECP (35 hours of active counterpulsation) or inactive EECP (over a 4- to 7-week period) to determine the safety and efficacy of EECP. The study demonstrated a significant improvement in the time to [[ST segment depression]] from baseline in the active EECP group (P=0.01). More active-EECP patients experienced a significant reduction in the frequency of anginal episodes (P=less than 0.05); however, the usage of [[Chronic stable angina treatment nitrates|nitroglycerin]] did not significantly change in both the groups. Thus, the study concluded that enhanced external counterpulsation significantly reduced [[chronic stable angina definition|angina]] and extended the time to exercise-induced ischemia in patients with [[Chronic stable angina symptoms|symptomatic CAD]].<ref name="pmid10362181">Arora RR, Chou TM, Jain D, Fleishman B, Crawford L, McKiernan T et al. (1999) [http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&retmode=ref&cmd=prlinks&id=10362181 The multicenter study of enhanced external counterpulsation (MUST-EECP): effect of EECP on exercise-induced myocardial ischemia and anginal episodes.] ''J Am Coll Cardiol'' 33 (7):1833-40. PMID: [http://pubmed.gov/10362181 10362181]</ref> | ||
Revision as of 16:06, 5 February 2013
|
Chronic stable angina Microchapters | ||
|
Classification | ||
|---|---|---|
| ||
| ||
|
Differentiating Chronic Stable Angina from Acute Coronary Syndromes | ||
|
Diagnosis | ||
|
Alternative Therapies for Refractory Angina | ||
|
Discharge Care | ||
|
Guidelines for Asymptomatic Patients | ||
|
Case Studies | ||
|
Chronic stable angina enhanced external counter pulsation On the Web | ||
|
FDA on Chronic stable angina enhanced external counter pulsation | ||
|
CDC onChronic stable angina enhanced external counter pulsation | ||
|
Chronic stable angina enhanced external counter pulsation in the news | ||
|
Blogs on Chronic stable angina enhanced external counter pulsation | ||
|
to Hospitals Treating Chronic stable angina enhanced external counter pulsation | ||
|
Risk calculators and risk factors for Chronic stable angina enhanced external counter pulsation | ||
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Phone:617-632-7753; Associate Editor(s)-In-Chief: John Fani Srour, M.D.; Jinhui Wu, M.D.; Lakshmi Gopalakrishnan, M.B.B.S.
Overview
Enhanced external counter pulsation (EECP) is another alternative therapy in the management of refractory angina. Most data from observational studies have demonstrated significant improvement in the exercise tolerance and reduction in the frequency of anginal symptoms as well as the use of nitroglycerin among patients treated with EECP.[1]
Enhanced External Counter Pulsation
Mechanisms of Benefit
- EECP has been postulated to decrease myocardial oxygen demand, enhance myocardial collateral flow via increased transmyocardial pressure, and improve endothelial function.
- Decrease peripheral vascular resistance and increase ventricular function.
- Increase arterial blood pressure and retrograde aortic blood flow during diastolic augmentation.
- Possible placebo effect associated with EECP has not been addressed in many studies, which have not included sham controls.
Approach
EECP uses three paired pneumatic cuffs that are applied to the lower extremities. The cuffs are sequentially inflated then deflated.
The therapy is usually administered over 7 weeks consisting of 35-one hour treatments.
Supportive Trial Data
Randomized-Controlled Study
- A multicenter, prospective, randomized, blinded, controlled trial involving 139 patients with angina, documented coronary artery disease and positive exercise treadmill test randomly assigned to receive either EECP (35 hours of active counterpulsation) or inactive EECP (over a 4- to 7-week period) to determine the safety and efficacy of EECP. The study demonstrated a significant improvement in the time to ST segment depression from baseline in the active EECP group (P=0.01). More active-EECP patients experienced a significant reduction in the frequency of anginal episodes (P=less than 0.05); however, the usage of nitroglycerin did not significantly change in both the groups. Thus, the study concluded that enhanced external counterpulsation significantly reduced angina and extended the time to exercise-induced ischemia in patients with symptomatic CAD.[2]
Registry Studies
- The International EECP Patient Registry (IEPR) involved 978 patients with refractory angina from 43 clinical centers to evaluate the safety and effectiveness of EECP in the management of chronic stable angina. Of the 978 patients analyzed, 70% had CCS class III or IV angina before the start of therapy, 62% used nitroglycerin, 81% had been previously revascularized, and 69% were considered unsuited for either PCI or CABG at the time of starting EECP. 86% patients completed a full 35-one hour course of EECP, of whom 81% reported a significant improvement of at least one angina class immediately after the last treatment.[3]
- A cohort study of 2,289 patients with refractory angina, from more than 100 centers, were evaluated to assess the safety and efficacy of EECP in the management of refractory angina. Angina class improved in 74% of patients with limiting angina (CCS class II-IV), with patients most impaired at baseline demonstrating the greatest improvement (39.5% of patients in CCS class III and IV improved 2 or more classes). The treatment was generally well tolerated and effective in patients ranging from 19 to 97 years.[4]
ACC/AHA Guidelines- Enhanced external counterpulsation (DO NOT EDIT)[5][6]
| Class IIb |
| "1. Enhanced external counterpulsation (EECP). (Level of Evidence: B)" |
References
- ↑ Urano H, Ikeda H, Ueno T, Matsumoto T, Murohara T, Imaizumi T (2001) Enhanced external counterpulsation improves exercise tolerance, reduces exercise-induced myocardial ischemia and improves left ventricular diastolic filling in patients with coronary artery disease. J Am Coll Cardiol 37 (1):93-9. PMID: 11153780
- ↑ Arora RR, Chou TM, Jain D, Fleishman B, Crawford L, McKiernan T et al. (1999) The multicenter study of enhanced external counterpulsation (MUST-EECP): effect of EECP on exercise-induced myocardial ischemia and anginal episodes. J Am Coll Cardiol 33 (7):1833-40. PMID: 10362181
- ↑ Barsness G, Feldman AM, Holmes DR, Holubkov R, Kelsey SF, Kennard ED et al. (2001) The International EECP Patient Registry (IEPR): design, methods, baseline characteristics, and acute results. Clin Cardiol 24 (6):435-42. PMID: 11403504
- ↑ Lawson WE, Hui JC, Lang G (2000) Treatment benefit in the enhanced external counterpulsation consortium. Cardiology 94 (1):31-5. PMID: 11111142
- ↑ Gibbons RJ, Chatterjee K, Daley J, Douglas JS, Fihn SD, Gardin JM et al. (1999)guidelines for the management of patients with chronic stable angina: executive summary and recommendations. A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients with Chronic Stable Angina).Circulation 99 (21):2829-48. PMID: 10351980
- ↑ Gibbons RJ, Abrams J, Chatterjee K, Daley J, Deedwania PC, Douglas JS et al. (2003) ACC/AHA 2002 guideline update for the management of patients with chronic stable angina--summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Chronic Stable Angina). Circulation 107 (1):149-58. PMID: 12515758